First Header Logo Second Header Logo

Elizabeth Palavecino

Concepts (305)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-Bacterial Agents
19
2023
286
2.920
Why?
Bacteremia
6
2023
53
2.200
Why?
Staphylococcal Infections
8
2014
57
1.860
Why?
Staphylococcus
2
2023
6
1.720
Why?
Staphylococcus aureus
8
2023
45
1.550
Why?
Bacteriological Techniques
9
2018
15
1.520
Why?
Pseudomonas aeruginosa
2
2020
27
1.490
Why?
Microbial Sensitivity Tests
14
2023
55
1.480
Why?
Bacteria
5
2018
45
1.130
Why?
beta-Lactamases
3
2022
7
1.110
Why?
Pneumocystis carinii
2
2020
6
1.060
Why?
Humans
55
2023
29396
1.050
Why?
Methicillin-Resistant Staphylococcus aureus
3
2014
24
1.020
Why?
Epstein-Barr Virus Infections
2
2022
10
1.010
Why?
Cross Infection
4
2019
46
0.920
Why?
Klebsiella pneumoniae
2
2020
8
0.900
Why?
BK Virus
1
2022
7
0.890
Why?
Methicillin Resistance
4
2023
13
0.880
Why?
Polyomavirus Infections
1
2022
21
0.870
Why?
Acinetobacter baumannii
1
2022
4
0.870
Why?
Influenza, Human
3
2019
123
0.850
Why?
Diagnostic Errors
3
2012
42
0.840
Why?
Hematopoietic Stem Cell Transplantation
1
2022
83
0.840
Why?
Reagins
1
2022
3
0.830
Why?
Syphilis
1
2022
11
0.830
Why?
Pseudomonas Infections
1
2020
9
0.770
Why?
Kidney Transplantation
2
2022
353
0.760
Why?
Neisseria gonorrhoeae
1
2020
3
0.740
Why?
Drug Contamination
2
2018
5
0.740
Why?
Azithromycin
1
2020
14
0.740
Why?
Gonorrhea
1
2020
7
0.740
Why?
Cytomegalovirus
1
2020
20
0.720
Why?
Bronchoalveolar Lavage Fluid
1
2020
68
0.710
Why?
Blood Platelets
4
2009
38
0.710
Why?
Immunocompromised Host
5
2020
43
0.700
Why?
Syringes
1
2018
5
0.670
Why?
Antifungal Agents
5
2018
34
0.670
Why?
Anesthetics
1
2018
19
0.660
Why?
Operating Rooms
1
2018
32
0.660
Why?
Strongyloidiasis
1
2017
3
0.630
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2017
17
0.620
Why?
Drug Resistance, Bacterial
3
2020
38
0.580
Why?
Bacterial Proteins
4
2022
77
0.520
Why?
Gram-Negative Bacteria
2
2013
7
0.510
Why?
Gram-Negative Bacterial Infections
2
2013
13
0.500
Why?
Platelet Transfusion
4
2009
16
0.450
Why?
Shiga Toxin
1
2012
2
0.450
Why?
Shiga-Toxigenic Escherichia coli
1
2012
3
0.450
Why?
Chromatography, Affinity
1
2012
15
0.450
Why?
Feces
1
2012
29
0.440
Why?
Enterococcus faecium
1
2012
1
0.440
Why?
Enterococcus faecalis
1
2012
10
0.440
Why?
Daptomycin
1
2012
2
0.440
Why?
Escherichia coli Infections
1
2012
37
0.430
Why?
Fatal Outcome
6
2018
78
0.420
Why?
Carbapenems
2
2022
3
0.410
Why?
Mycoses
2
2011
13
0.410
Why?
Fungi
1
2011
5
0.400
Why?
Laboratories, Hospital
1
2010
3
0.370
Why?
Bacterial Infections
3
2006
42
0.370
Why?
Pathology, Molecular
1
2010
16
0.370
Why?
Mycobacterium Infections
1
2010
1
0.370
Why?
Corynebacterium Infections
1
2010
2
0.370
Why?
Mycobacterium
1
2010
2
0.370
Why?
Endocarditis, Bacterial
1
2010
9
0.370
Why?
Herpesvirus 4, Human
2
2022
9
0.350
Why?
Male
16
2020
17930
0.350
Why?
Bone Marrow Diseases
1
2009
2
0.350
Why?
Pneumocystis Infections
1
2009
2
0.350
Why?
Lymphoma, T-Cell, Cutaneous
1
2009
6
0.340
Why?
Bone Marrow
1
2009
61
0.330
Why?
Time Factors
6
2018
2010
0.330
Why?
United States
7
2020
3673
0.320
Why?
Amphotericin B
3
2018
10
0.320
Why?
Adult
13
2020
8503
0.320
Why?
Lung Diseases, Fungal
2
2018
3
0.320
Why?
Polymerase Chain Reaction
2
2021
173
0.310
Why?
Molecular Diagnostic Techniques
2
2020
9
0.300
Why?
Blood Transfusion
2
2004
64
0.300
Why?
Influenza A virus
2
2019
21
0.300
Why?
Clinical Laboratory Techniques
2
2021
18
0.290
Why?
Drug Resistance, Fungal
2
2003
2
0.280
Why?
Fluconazole
2
2003
7
0.280
Why?
Female
18
2020
18304
0.280
Why?
Child, Preschool
4
2020
1170
0.270
Why?
Drug Resistance, Microbial
2
2022
11
0.270
Why?
Erythromycin
2
2002
6
0.270
Why?
Sepsis
2
2004
149
0.260
Why?
Sensitivity and Specificity
4
2020
533
0.260
Why?
Blood Component Transfusion
1
2004
10
0.250
Why?
Streptococcus pyogenes
2
2003
17
0.250
Why?
Seasons
2
2019
84
0.250
Why?
DNA, Viral
2
2022
47
0.250
Why?
Streptococcal Infections
2
2003
20
0.250
Why?
Middle Aged
11
2019
10913
0.250
Why?
Candidiasis
1
2003
2
0.230
Why?
AIDS-Related Opportunistic Infections
1
2003
10
0.230
Why?
Candida albicans
1
2003
11
0.230
Why?
Esophageal Diseases
1
2003
7
0.230
Why?
Mitosporic Fungi
1
2003
2
0.230
Why?
Cephalosporins
1
2023
7
0.230
Why?
Antibodies, Bacterial
2
2022
31
0.220
Why?
Viral Load
1
2022
67
0.220
Why?
Drug Resistance, Multiple, Bacterial
1
2022
15
0.220
Why?
Pneumonia
2
2020
62
0.210
Why?
Cell Culture Techniques
2
2014
165
0.210
Why?
Streptococcus pneumoniae
1
2002
40
0.210
Why?
Syphilis Serodiagnosis
1
2022
5
0.210
Why?
Treponema pallidum
1
2022
7
0.210
Why?
Immunoassay
1
2021
13
0.200
Why?
Bacterial Typing Techniques
2
2014
9
0.190
Why?
Carrier State
1
2020
21
0.190
Why?
Membrane Proteins
1
2002
256
0.190
Why?
Antibodies, Viral
1
2020
57
0.190
Why?
Cefixime
1
2020
1
0.190
Why?
Cerebrospinal Fluid Otorrhea
1
2020
2
0.190
Why?
HIV Seronegativity
1
2020
4
0.190
Why?
Pharynx
1
2020
10
0.190
Why?
Penicillins
1
2020
8
0.190
Why?
Tetracycline
1
2020
11
0.190
Why?
Ceftriaxone
1
2020
11
0.190
Why?
Hospitals
1
2020
89
0.180
Why?
Virology
1
2020
1
0.180
Why?
Mycological Typing Techniques
1
2020
1
0.180
Why?
Bronchoalveolar Lavage
1
2020
15
0.180
Why?
Pneumonia, Pneumocystis
1
2020
6
0.180
Why?
Cytomegalovirus Infections
1
2020
25
0.180
Why?
Enterobacteriaceae
2
2017
9
0.180
Why?
Clindamycin
3
2007
18
0.180
Why?
Health Facilities
1
2019
11
0.180
Why?
North Carolina
3
2020
1426
0.170
Why?
Drug Packaging
1
2018
4
0.170
Why?
Homosexuality, Male
1
2020
76
0.170
Why?
Child
6
2016
2227
0.170
Why?
Blood Preservation
3
2009
9
0.170
Why?
Ascomycota
1
2018
4
0.160
Why?
Diagnosis, Differential
1
2020
493
0.160
Why?
Strongyloides stercoralis
1
2017
3
0.160
Why?
Piperacillin
1
2017
5
0.160
Why?
Penicillanic Acid
1
2017
5
0.160
Why?
Pharmacists
1
2018
18
0.160
Why?
Antiparasitic Agents
1
2017
6
0.160
Why?
Cryptococcosis
1
2017
4
0.160
Why?
Ivermectin
1
2017
9
0.160
Why?
Plateletpheresis
2
2009
3
0.160
Why?
Case-Control Studies
1
2020
861
0.150
Why?
Aged
5
2019
9538
0.150
Why?
Colony Count, Microbial
3
2010
17
0.140
Why?
Culture Media
2
2009
39
0.140
Why?
Predictive Value of Tests
3
2020
795
0.140
Why?
Sphingomonas
1
2015
1
0.140
Why?
Meningitis
1
2015
9
0.140
Why?
Virulence
2
2007
21
0.140
Why?
Practice Guidelines as Topic
1
2018
375
0.130
Why?
Adolescent
5
2016
3273
0.130
Why?
Influenza A Virus, H1N1 Subtype
1
2016
49
0.130
Why?
Community-Acquired Infections
2
2007
31
0.130
Why?
Anemia, Hemolytic, Autoimmune
1
2015
4
0.130
Why?
Mucormycosis
1
2014
2
0.130
Why?
Animals
3
2017
7328
0.130
Why?
Young Adult
4
2016
2422
0.130
Why?
Autoantibodies
1
2015
42
0.120
Why?
Nucleic Acid Amplification Techniques
1
2014
8
0.120
Why?
Influenza B virus
1
2014
20
0.120
Why?
Chile
3
2006
6
0.120
Why?
Penicillin-Binding Proteins
1
2014
1
0.120
Why?
Electrophoresis
1
2014
7
0.120
Why?
Multiple Organ Failure
2
2014
9
0.120
Why?
Fluorescent Antibody Technique
1
2014
85
0.120
Why?
Microscopy, Fluorescence
1
2014
81
0.120
Why?
Computational Biology
1
2014
86
0.120
Why?
United States Food and Drug Administration
2
2020
44
0.110
Why?
Diabetes Complications
1
2014
171
0.110
Why?
Diabetes Mellitus, Type 1
1
2014
180
0.110
Why?
Hematuria
1
2012
7
0.110
Why?
Urinalysis
1
2012
19
0.110
Why?
Lactobacillus
1
2012
8
0.110
Why?
Gentamicins
1
2012
4
0.110
Why?
Mupirocin
1
2012
2
0.100
Why?
Peritonitis
1
2012
10
0.100
Why?
Catheter-Related Infections
1
2012
10
0.100
Why?
Anti-Infective Agents, Local
1
2012
13
0.100
Why?
Antibiotic Prophylaxis
1
2012
29
0.100
Why?
Peritoneal Dialysis
1
2012
22
0.100
Why?
Hyphae
1
2011
1
0.100
Why?
Unnecessary Procedures
1
2011
9
0.100
Why?
Cerebrospinal Fluid
1
2011
13
0.100
Why?
Cushing Syndrome
1
2010
1
0.100
Why?
Nocardia asteroides
1
2010
2
0.100
Why?
Mass Screening
1
2012
226
0.100
Why?
Staphylococcus epidermidis
1
2010
4
0.090
Why?
Carcinoid Tumor
1
2010
22
0.090
Why?
Rifampin
1
2010
7
0.090
Why?
Ventriculostomy
1
2010
11
0.090
Why?
Cerebrospinal Fluid Shunts
1
2010
6
0.090
Why?
Minocycline
1
2010
11
0.090
Why?
Urine
1
2011
59
0.090
Why?
Education, Continuing
1
2010
5
0.090
Why?
Coated Materials, Biocompatible
1
2010
17
0.090
Why?
Organizational Innovation
1
2010
30
0.090
Why?
Calorimetry
1
2009
3
0.090
Why?
Blood
1
2009
8
0.090
Why?
Equipment Contamination
1
2009
11
0.090
Why?
Phlebotomy
1
2009
17
0.090
Why?
Geotrichosis
1
2009
1
0.090
Why?
Geotrichum
1
2009
1
0.090
Why?
Echinocandins
1
2009
4
0.090
Why?
Lipopeptides
1
2009
5
0.090
Why?
Neutropenia
1
2009
23
0.090
Why?
Phenotype
2
2002
633
0.090
Why?
DNA, Bacterial
2
2007
17
0.090
Why?
Bacterial Capsules
1
2009
5
0.090
Why?
Microscopy, Atomic Force
1
2009
6
0.090
Why?
Bacterial Adhesion
1
2009
7
0.090
Why?
Respiratory Syncytial Virus, Human
1
2008
2
0.080
Why?
Respiratory Syncytial Virus Infections
1
2008
9
0.080
Why?
Spleen
1
2009
82
0.080
Why?
Ustilaginales
1
2008
3
0.080
Why?
Fungemia
1
2008
3
0.080
Why?
Short Bowel Syndrome
1
2008
8
0.080
Why?
Antiviral Agents
1
2008
101
0.080
Why?
Skin
1
2009
205
0.080
Why?
Catheterization, Central Venous
1
2008
60
0.080
Why?
Vancomycin Resistance
1
2007
2
0.070
Why?
Molecular Epidemiology
1
2007
20
0.070
Why?
Evolution, Molecular
1
2007
36
0.070
Why?
Antibodies, Monoclonal
1
2008
197
0.070
Why?
Lung Neoplasms
1
2010
388
0.070
Why?
Disease Reservoirs
1
2006
1
0.070
Why?
Hospitals, University
1
2006
23
0.070
Why?
Bartonella henselae
1
2006
2
0.070
Why?
Serotyping
2
2003
15
0.070
Why?
Quality Control
1
2006
38
0.070
Why?
Cats
1
2006
105
0.070
Why?
Electrophoresis, Gel, Pulsed-Field
2
2003
6
0.060
Why?
Blood Donors
1
2004
12
0.060
Why?
Contact Tracing
2
2020
8
0.060
Why?
Clostridium difficile
1
2004
12
0.060
Why?
Clostridium Infections
1
2004
9
0.060
Why?
Intestinal Diseases
1
2004
18
0.060
Why?
Methicillin
1
2004
1
0.060
Why?
Sterilization
1
2003
2
0.060
Why?
Erythrocytes
1
2003
45
0.060
Why?
Pharyngeal Diseases
1
2003
8
0.060
Why?
Candidiasis, Oral
1
2003
10
0.060
Why?
Cryptococcus neoformans
1
2003
1
0.060
Why?
Candida
1
2003
7
0.060
Why?
CD4 Lymphocyte Count
1
2003
32
0.060
Why?
Risk Factors
2
2018
3588
0.060
Why?
Prospective Studies
3
2014
2040
0.050
Why?
Methyltransferases
1
2002
4
0.050
Why?
Phenazines
1
2002
1
0.050
Why?
Gentian Violet
1
2002
2
0.050
Why?
Serologic Tests
1
2002
10
0.050
Why?
False Negative Reactions
1
2002
21
0.050
Why?
Infant
2
2016
975
0.050
Why?
Antibodies, Neutralizing
1
2020
17
0.050
Why?
Immunoglobulin G
2
2015
105
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2001
248
0.050
Why?
Alternaria
1
2018
1
0.040
Why?
Patient Care Management
1
2018
17
0.040
Why?
Knee
1
2018
31
0.040
Why?
Biopsy, Fine-Needle
1
2017
50
0.040
Why?
Program Evaluation
1
2018
175
0.040
Why?
Patient Care Team
1
2018
124
0.040
Why?
Attitude of Health Personnel
1
2018
163
0.030
Why?
Disease Outbreaks
2
2008
35
0.030
Why?
Aged, 80 and over
2
2014
3733
0.030
Why?
Cryoglobulins
1
2015
5
0.030
Why?
Reproducibility of Results
1
2017
727
0.030
Why?
Erythrocyte Transfusion
1
2015
32
0.030
Why?
Infant, Newborn
1
2016
604
0.030
Why?
Reagent Strips
1
2012
4
0.030
Why?
False Positive Reactions
1
2012
25
0.030
Why?
Emergency Service, Hospital
1
2016
439
0.030
Why?
Pseudomonas
1
2012
6
0.030
Why?
Survival Analysis
1
2013
440
0.030
Why?
Length of Stay
1
2013
295
0.030
Why?
Retrospective Studies
2
2012
3134
0.020
Why?
Nocardia Infections
1
2010
2
0.020
Why?
Adrenocorticotropic Hormone
1
2010
22
0.020
Why?
Prosthesis-Related Infections
1
2010
23
0.020
Why?
Agar
1
2009
1
0.020
Why?
Chromogenic Compounds
1
2009
1
0.020
Why?
Color
1
2009
13
0.020
Why?
Magnetic Resonance Imaging
1
2015
1221
0.020
Why?
Surface Properties
1
2009
32
0.020
Why?
Water
1
2009
52
0.020
Why?
Population Surveillance
1
2008
119
0.020
Why?
Cohort Studies
1
2012
1699
0.020
Why?
Models, Biological
1
2009
373
0.020
Why?
Blood-Borne Pathogens
1
2006
7
0.020
Why?
Seroepidemiologic Studies
1
2006
9
0.020
Why?
Fluorescent Antibody Technique, Indirect
1
2006
13
0.020
Why?
Chi-Square Distribution
1
2006
293
0.020
Why?
Treatment Outcome
1
2013
3119
0.020
Why?
Evaluation Studies as Topic
1
2005
39
0.020
Why?
Empyema, Pleural
1
2003
6
0.010
Why?
Pharyngitis
1
2003
11
0.010
Why?
Disease Transmission, Infectious
1
2003
14
0.010
Why?
Pneumonia, Bacterial
1
2003
31
0.010
Why?
Shock, Septic
1
2003
29
0.010
Why?
Family Health
1
2003
78
0.010
Why?
Drug Therapy, Combination
1
2003
273
0.010
Why?
Genotype
1
2003
735
0.010
Why?
Palavecino's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (305)
Explore
_
Co-Authors (20)
Explore
_
Similar People (52)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_